Study to evaluate renal function of everolimus plus tacrolimus in liver transplant patients

Registry ID

EUCTR2011-003118-17

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Novartis Pharma GmbH

Start date

2011-12-29

Last update

2026-08-16

Conditions

• liver transplantation

Summary

To demonstrate that an immunosuppressive regimen based on everolimus (EVR) in co-exposure with tacrolimus (TAC) has superior efficacy compared to tacrolimus alone on estimated glomerular filtration rate (MDRD-4 formula) at Month 12 in de novo liver transplant recipients.

Locations

• , , Germany

View on source registry